S.204 – Right To Try Act Of 2017

This legislation was passed by Congress on May 30, 2018. The bill amends the Federal Food, Drug, and Cosmetic Act to exempt—from specified requirements and restrictions under that Act and other laws—the provision of certain unapproved, investigational drugs to a terminally ill health care consumer who has exhausted approved treatment options and is unable to participate in a clinical trial involving the drugs . . .